NCT01760109View on ClinicalTrials.gov

Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection

PHASE4CompletedINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Respiratory Tract InfectionsUrinary Tract Infections

Interventions

DRUG

Piperacillin Sodium and Sulbactam Sodium

1.5-3.0g,iv,bid 7-14 days serious infections 6.0-12.0g,iv,tid for 7-14 days

Trial Locations (1)

400020

Chongqing Red Cross hospital, Chongqing

All Listed Sponsors

lead

Xiangbei Welman Pharmaceutical Co., Ltd

INDUSTRY

NCT01760109 - Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection | Biotech Hunter | Biotech Hunter